Last reviewed · How we verify

Normal Nicotine Content Cigarettes

University of Minnesota · Phase 3 active Small molecule

Normal nicotine content cigarettes deliver standard levels of nicotine to study the relationship between nicotine exposure and smoking behavior or health outcomes in a controlled research setting.

Normal nicotine content cigarettes deliver standard levels of nicotine to study the relationship between nicotine exposure and smoking behavior or health outcomes in a controlled research setting. Used for Nicotine dependence research, Smoking behavior modification studies.

At a glance

Generic nameNormal Nicotine Content Cigarettes
Also known asConventional Nicotine Content Cigarettes
SponsorUniversity of Minnesota
TargetNicotinic acetylcholine receptors
ModalitySmall molecule
Therapeutic areaAddiction Medicine / Smoking Cessation
PhasePhase 3

Mechanism of action

This appears to be a research product from the University of Minnesota designed as a control or comparison arm in smoking behavior studies. Normal nicotine cigarettes serve as a baseline to compare against reduced-nicotine or modified cigarettes in Phase 3 trials examining nicotine dependence, smoking cessation, or harm reduction strategies.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results